Delivery Order SPE2DB20D1100-SPE2DB25FE6E5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,362.54 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on August 18, 2025, with completion expected by August 19, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under an open contracting vehicle. The product will be delivered to the company's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets in quantities of 90 units. This firm fixed-price delivery order, valued at $1,351.98, represents a competitive award with no set-aside designation and is scheduled for completion by September 10, 2025. The contract is being fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $8,139.90 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count) on September 8, 2025, with an ultimate completion date of September 9, 2025. This competitively awarded, firm fixed-price delivery order is non-set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The order represents a single transaction under AmerisourceBergen Drug Corp's existing contract...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency Medical Supply Chain on July 21, 2025, for Valsartan-HCT 320-25 mg tablets in a 90-count supply. The contract is valued at $3,709.25 and operates under a firm fixed-price delivery order structure with an ultimate completion date of July 22, 2025. This award represents a non-set-aside, competitively awarded contract, demonstrating the vendor's continued capability...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count package) at a ceiling value of $3,756.36. This firm fixed price delivery order represents a non-competitive set-aside and is scheduled for completion by September 12, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, leveraging the company's established...
- The Defense Logistics Agency awarded a delivery order valued at $4,733.29 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-25 mg tablets (90-count bottles) under a firm fixed-price contract. The award was made on August 14, 2025, with an ultimate completion date of August 15, 2025, and represents a non-set-aside competitive procurement. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate office and primary...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,542.97 to AmerisourceBergen Drug Corp for Valsartan-HCTZ 320-25 mg tablets (90-count supply). This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. As a child delivery order under a...
- The Defense Logistics Agency awarded a delivery order valued at $3,286.65 to AmerisourceBergen Drug Corp for 90-count bottles of Valsartan-HCTZ 320-25 mg tablets. This is a firm fixed price, competitively awarded delivery order with no set-aside designation, with an ultimate completion date of August 14, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $5,582.42 to AmerisourceBergen Drug Corp for the supply of Valsartan-HCTZ 160-12.5 mg tablets (90-count) on August 19, 2025, with completion scheduled for August 20, 2025. This non-competitive delivery order utilizes firm fixed pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Valsartan-HCTZ 320-25 mg tablets in a quantity of 90 units, with a ceiling value of $5,610.41. This is a firm fixed-price delivery order issued under a competitive procurement with no set-aside designation. The contract specifies a place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of September 5, 2025. This delivery order is a...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE6E5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Valsartan-HCTZ 320-25 mg tablets (90-count supply). The contract is valued at $1,444.94 with a firm fixed-price structure and was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025. This delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken facility. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999.9 billion prime contract running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The parent IDC enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide, positioning the company as a critical vendor within the DLA Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 9/11/25 |